What this medicine is commonly used for
Procurement teams reference Lenacapavir when aligning formulary decisions, documenting a named patient request, or preparing a quotation for a destination country where the product is not routinely stocked.
Informational only. Treatment decisions belong to qualified clinicians and to local labeling.
Shortage and sourcing context
Supply routes differ by indication and by country programme, and access is often organized through national or donor channels rather than ordinary wholesale. Requests should state the destination country and the programme context up front.
How it is presented
Examples of presentations referenced for this medicine. Actual market presentations vary by country and registration, so check the pack in front of you.
- Solution for injection
- Tablet
Who typically asks us about this medicine
- Patients and families who cannot fill a prescription locally
- Hospital pharmacies managing formulary access during a shortage
- Clinics with defined treatment pathways and continuity of care
- Procurement teams coordinating licensed cross-border sourcing
Full reference text(expand)
Lenacapavir (Sunlenca, Yeztugo): A long-acting HIV capsid inhibitor dosed at extended intervals, used in multidrug-resistant infection and in prevention programmes. Procurement-oriented reference for licensed buyers - not medical advice, and availability depends on region and authorization.
Procurement context
Procurement teams reference Lenacapavir when aligning formulary decisions, documenting a named patient request, or preparing a quotation for a destination country where the product is not routinely stocked.
What makes it hard to source
Supply routes differ by indication and by country programme, and access is often organized through national or donor channels rather than ordinary wholesale. Requests should state the destination country and the programme context up front.